FDA approves new use of popular diabetes drug
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"FDA approves new use of popular diabetes drug" is generating significant coverage in the Business category, with 5 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Drug Topics, Forbes, 10TV and Endpoints News. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 52d ago.
Quick answers
Why is "FDA approves new use of popular diabetes drug" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (5)
- Tirzepatide Receives Expanded Approval for MACE in Patients With T2D Drug Topics · 55d ago
- FDA Approves Mounjaro (Tirzepatide) For Reducing Cardiovascular Risk In Adults with Type 2 Diabetes. Here Are The Best GLP-1 Providers Forbes · 55d ago
- Mounjaro gets FDA approval to lower heart attack, stroke risk in diabetes patients 10TV · 55d ago
- Mounjaro scores FDA approval to reduce CV risk; Teva to buy an approved drug Endpoints News · 55d ago
- FDA approves new use of popular diabetes drug Action News 5 · 55d ago
Topics
Related trends
Popular kids' toothpastes among 4M tubes recalled nationwide
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Telehealth leapfrogs FDA approval with off-label GLP-1 prescriptions for addiction
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Startup Deploys AI-Engineered Virus on Human Patient
A startup deploys an artificial intelligence-designed virus in a human patient for the first time.
Roche builds blockbuster BTK case for fenebrutinib in multiple sclerosis as FDA decision approaches
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
What to know about GLP-1s and cannabis use
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
FDA Announces Nationwide Recall of More Than 4 Million Tubes of Toothpaste
Federal regulators have announced a nationwide recall affecting more than four million tubes of adult and children's toothpaste.